Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency

被引:5
|
作者
Markus, Bernadett [1 ]
Veszeli, Nora [2 ]
Temesszentandrasi, Gyorgy [2 ]
Farkas, Henriette [2 ]
Kalabay, Laszlo [1 ,3 ]
机构
[1] Semmelweis Univ, Dept Family Med, Budapest POB 2,Kutvolgyi Str 4, H-1125 Budapest, Hungary
[2] Semmelweis Univ, Dept Internal Med 3, Hungarian Angioedema Reference Ctr, Budapest, Hungary
[3] Semmelweis Univ, POB 2, H-1428 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
Fetuin-A; Tumor necrosis factor alpha; C-reactive protein; Hereditary angioedema; C1 inhibitor deficiency; ALPHA(2)-HEREMANS-SCHMID GLYCOPROTEIN/FETUIN-A; METABOLIC SYNDROME; HS-GLYCOPROTEIN; BRADYKININ; ALPHA-2-HS-GLYCOPROTEIN; ACCUMULATION; ASSOCIATION; INHIBITOR; CHILDREN; DISEASE;
D O I
10.1186/s13023-019-0995-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background and aims: Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is characterized by localized, non-pitting, and transient swelling of submucosal or subcutaneous region. Human fetuin-A is a multifunctional glycoprotein that belongs to the proteinase inhibitor cystatin superfamily and has structural similarities to the high molecular weight kininogen. Fetuin-A is also known a negative acute phase reactant with anti-inflammatory characteristics. In this study we aimed to determine serum fetuin-A, C-reactive protein (CRP) and tumor necrosis factor alpha (TNF alpha) concentrations in patients with C1-INH-HAE during symptom-free period and during attacks and compare them to those of healthy controls. Further we analyzed possible relationship among these parameters as well as D-dimer levels which was known as marker of HAE attacks. Patients and methods: Serum samples of 25 C1-INH-HAE patients (8 men, 17 women, age: 33.1 +/- 6.9 years, mean +/- SD) were compared to 25 healthy controls (15 men, 10 women, age: 32.5 +/- 7.8 years). Serum fetuin-A and TNF alpha concentrations were determined by ELISA, CRP and D-dimer by turbidimetry. Results: Compared to healthy controls patients with C1-INH-HAE in the symptom-free period had significantly decreased serum fetuin-A 258 mu g/ml (224-285) vs. 293 mu g/ml (263-329), (median (25-75% percentiles, p = 0.035) and TNF alpha 2.53 ng/ml (1.70-2.83) vs. 3.47 ng/ml (2.92-4.18, p = 0.0008) concentrations. During HAE attacks fetuin-A levels increased from 258 (224-285) mu g/ml to 287 (261-317) mu g/ml (p = 0.021). TNF alpha and CRP levels did not change significantly. We found no significant correlation among fetuin-A CRP, TNF alpha and D-dimer levels in any of these three groups. Conclusions: Patients with C1-INH-HAE have decreased serum fetuin-A concentrations during the symptom-free period. Given the anti-inflammatory properties of fetuin-A, the increase of its levels may contribute to the counter-regulation of edema formation during C1-INH-HAE attacks.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Nailfold videocapillaroscopic findings in hereditary angioedema with C1-inhibitor deficiency
    Marcelli, Cesoni A.
    Bova, M.
    Petraroli, A.
    Loffredo, S.
    Ferrara, A. L.
    Spadaro, G.
    Genovese, A.
    ALLERGY, 2018, 73 : 286 - 287
  • [22] Assisted reproductive techniques in patients with hereditary angioedema due to C1-inhibitor deficiency
    Cascales, T. Navarro
    Alvarez, F. Adrianzen
    Cabanas, R.
    Roche, O.
    Iniesta, S.
    Caballero, T.
    ALLERGY, 2023, 78
  • [23] Life expectancy in Italian patients with hereditary angioedema due to C1-inhibitor deficiency
    Perego, Francesca
    Gidaro, Antonio
    Zanichelli, Andrea
    Cancian, Mauro
    Arcoleo, Francesco
    Senter, Riccardo
    Bova, Maria
    De Pasquale, Tiziana
    Guarino, Maria Domenica
    Lo Pizzo, Mariangela
    Frigerio, Chiara
    Duca, Pier Giorgio
    Cicardi, Marco
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (05): : 1772 - 1774
  • [24] A novel prophylaxis in hereditary angioedema with C1-inhibitor deficiency: administration of C1-inhibitor during erythema marginatum
    Kohalmi, K., V
    Veszeli, N.
    Temesszentandrasi, G.
    Cervenak, L.
    Varga, L.
    Farkas, H.
    ALLERGY, 2017, 72 : 595 - 595
  • [25] Tryptase and histamine in patients with angioedema due to C1-inhibitor deficiency (Hereditary Angioedema, HAE) and in patients with mastocytosis
    Obtulowicz, Aleksander
    Pirowska, Magdalena
    Dyga, Wojciech
    Czarnobilska, Ewa
    Wojas-Pelc, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2015, 20 (02): : 106 - 110
  • [26] SERUM CONCENTRATIONS OF INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR-ALPHA, AND C-REACTIVE PROTEIN IN PATIENTS UNDERGOING MAJOR OPERATIONS
    KRAGSBJERG, P
    HOLMBERG, H
    VIKERFORS, T
    EUROPEAN JOURNAL OF SURGERY, 1995, 161 (01) : 17 - 22
  • [27] Real-life experience with recombinant human C1-inhibitor in treatment of hereditary angioedema with C1-inhibitor deficiency
    Farkas, Henriette
    Veszeli, Nora
    Kohalmi, Kinga V.
    Varga, Lilian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB49 - AB49
  • [28] The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency
    Zsuzsanna Zotter
    Dorottya Csuka
    Erika Szabó
    Ibolya Czaller
    Zsuzsanna Nébenführer
    György Temesszentandrási
    George Fust
    Lilian Varga
    Henriette Farkas
    Orphanet Journal of Rare Diseases, 9
  • [29] Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency
    Zanichelli, Andrea
    Montinaro, Vincenzo
    Triggiani, Massimo
    Arcoleo, Francesco
    Visigalli, Debora
    Cancian, Mauro
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (02) : 103 - 110
  • [30] Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency
    Zotter, Zsuzsanna
    Nagy, Zsolt
    Patocs, Attila
    Csuka, Dorottya
    Veszeli, Nora
    Kohalmi, Kinga Viktoria
    Farkas, Henriette
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12